Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Surrogate endpoints: wishful thinking or reality?

× No keyword cloud information.

18 in total

Review 1. Biomarkers in oncology drug development.

Authors: Darren R Hodgson; Robin D Whittaker; Athula Herath; Dereck Amakye; Glen Clack
Journal: Mol Oncol Date: 2008-12-11 Impact factor: 6.603

2. Progression-free survival and time to progression as surrogate markers of overall survival in patients with advanced gastric cancer: analysis of 36 randomized trials.

Authors: Kohei Shitara; Junko Ikeda; Tomoya Yokota; Daisuke Takahari; Takashi Ura; Kei Muro; Keitaro Matsuo
Journal: Invest New Drugs Date: 2011-02-25 Impact factor: 3.850

Review 3. Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer?

Authors: Lothar R Pilz; Christian Manegold; Gerald Schmid-Bindert
Journal: Transl Lung Cancer Res Date: 2012-03

Review 4. PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials.

Authors: Edoardo Francini; Roberto Petrioli; Giulia Rossi; Letizia Laera; Giandomenico Roviello
Journal: Tumour Biol Date: 2014-09-07

5. A new estimation with minimum trace of asymptotic covariance matrix for incomplete longitudinal data with a surrogate process.

Authors: Baojiang Chen; Jing Qin
Journal: Stat Med Date: 2013-06-07 Impact factor: 2.373

6. Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes.

Authors: Yoshihiro Matsubara; Satomi Sakabayashi; Tsutomu Nishimura; Takanori Ishida; Noriaki Ohuchi; Satoshi Teramukai; Masanori Fukushima
Journal: Int J Clin Oncol Date: 2011-05-03 Impact factor: 3.402

10. Correlation between overall survival and other endpoints in clinical trials of second-line chemotherapy for patients with advanced gastric cancer.

Authors: Kohei Shitara; Keitaro Matsuo; Kei Muro; Toshihiko Doi; Atsushi Ohtsu
Journal: Gastric Cancer Date: 2013-06-05 Impact factor: 7.370

Surrogate endpoints: wishful thinking or reality?